Showing results (61-70 of 96) with videos related to

Sort By:
Pageof 10
The American Journal of Pathology|August 23, 2019
Proresolving Mediators LXB4 and RvE1 Regulate Inflammation in Stromal Cells from Patients with Shoulder Tendon TearsStephanie G Dakin, Romain A Colas, Kim Wheway, et al.
European Urology Focus|January 15, 2022
Nocturia and Chronic Kidney Disease: Systematic Review and Nominal Group Technique Consensus on Primary Care Assessment and TreatmentAlex Ridgway, Nikki Cotterill, Shoba Dawson, et al.
Cancer|June 17, 2015
Quality of patient-reported outcome reporting across cancer randomized controlled trials according to the CONSORT patient-reported outcome extension: A pooled analysis of 557 trialsFabio Efficace, Peter Fayers, Andrea Pusic, et al.
The Journal of Pathology|March 3, 2010
Oncogenic KRAS is not necessary for Wnt signalling activation in APC-associated FAP adenomasAntònia Obrador-Hevia, Suet-Feung Chin, Sara González, et al.
Systematic Reviews|November 15, 2018
Systematic review of the surgical management of rotator cuff repair with an augmentative patch: a feasibility study protocolGemma Greenall, Andrew Carr, David Beard, et al.
European Urology Focus|January 14, 2022
Association of Sleep Disorders with Nocturia: A Systematic Review and Nominal Group Technique Consensus on Primary Care Assessment and TreatmentEmma Papworth, Shoba Dawson, Emily J Henderson, et al.
European Urology Focus|January 8, 2022
Assessment and Treatment of Nocturia in Endocrine Disease in a Primary Care Setting: Systematic Review and Nominal Group Technique ConsensusShoba Dawson, Lorna Duncan, Ahmed Ahmed, et al.
European Urology Focus|February 1, 2022
Evaluation and Treatment in Urology for Nocturia Caused by Nonurological Mechanisms: Guidance from the PLANET StudyMatthew Smith, Shoba Dawson, Robert C Andrews, et al.
Carcinogenesis|January 11, 2007
DNA repair gene polymorphisms and genetic predisposition to cutaneous melanomaJoanne E Povey, Fatemeh Darakhshan, Karen Robertson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 12, 2020
Differences in Patient-Reported Outcomes That Are Most Frequently Detected in Randomized Controlled Trials in Patients With Solid Tumors: A Pooled Analysis of 229 TrialsJohannes M Giesinger, Jane Blazeby, Neil K Aaronson, et al.
Pageof 10